165 related articles for article (PubMed ID: 30829709)
21. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
22. Ultrasonographic features of medullary thyroid carcinoma and their diagnostic values.
Cai S; Liu H; Li WB; Ouyang YS; Zhang B; Li P; Wang XL; Zhang XY; Li JC; Jiang YX
Chin Med J (Engl); 2010 Nov; 123(21):3074-8. PubMed ID: 21162958
[TBL] [Abstract][Full Text] [Related]
23. Clinical challenges with calcitonin-negative medullary thyroid carcinoma.
Samà MT; Rossetto Giaccherino R; Gallo M; Felicetti F; Maletta F; Bonelli N; Piovesan A; Palestini N; Ghigo E; Arvat E
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2023-9. PubMed ID: 27125958
[TBL] [Abstract][Full Text] [Related]
24. The relevance of preoperative ultrasound cervical mapping in patients with thyroid cancer.
Kocharyan D; Schwenter F; Bélair M; Nassif E
Can J Surg; 2016 Apr; 59(2):113-7. PubMed ID: 27007092
[TBL] [Abstract][Full Text] [Related]
25. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
[TBL] [Abstract][Full Text] [Related]
26. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
27. Medullary Thyroid Carcinoma: Imaging.
Delorme S; Raue F
Recent Results Cancer Res; 2015; 204():91-116. PubMed ID: 26494385
[TBL] [Abstract][Full Text] [Related]
28. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
[TBL] [Abstract][Full Text] [Related]
29. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
31. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
Trimboli P; Giovanella L
Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound features of medullary thyroid carcinoma correlate with cancer aggressiveness: a retrospective multicenter study.
Trimboli P; Giovanella L; Valabrega S; Andrioli M; Baldelli R; Cremonini N; Rossi F; Guidobaldi L; Barnabei A; Rota F; Paoloni A; Rizza L; Fattorini G; Latini M; Ventura C; Falasca P; Orlandi F; Crescenzi A; D'Ambrosio F; Cantisani V; Romanelli F; Negro R; Saggiorato E; Appetecchia M
J Exp Clin Cancer Res; 2014 Oct; 33(1):87. PubMed ID: 25344474
[TBL] [Abstract][Full Text] [Related]
33. [Medullary thyroid carcinoma].
Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
[TBL] [Abstract][Full Text] [Related]
34. Concurrent medullary and papillary carcinoma of thyroid.
Ateşpare A; Çalış AB; Çelik Ö; Yener N; Vural Ç
Kulak Burun Bogaz Ihtis Derg; 2015; 25(3):170-3. PubMed ID: 26050858
[TBL] [Abstract][Full Text] [Related]
35. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
36. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
37. Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer.
Allelein S; Ehlers M; Morneau C; Schwartz K; Goretzki PE; Seppel T; Feldkamp J; Krieg A; Knoefel WT; Kuebart A; Haase M; Dringenberg T; Schmid C; Schott M
Horm Metab Res; 2018 Jan; 50(1):23-28. PubMed ID: 29169190
[TBL] [Abstract][Full Text] [Related]
38. Medullary thyroid carcinoma: comparison with papillary thyroid carcinoma and application of current sonographic criteria.
Lee S; Shin JH; Han BK; Ko EY
AJR Am J Roentgenol; 2010 Apr; 194(4):1090-4. PubMed ID: 20308516
[TBL] [Abstract][Full Text] [Related]
39. The Diagnostic Value of Ultrasound in Medullary Thyroid Carcinoma: A Comparison With Computed Tomography.
Wang L; Kou H; Chen W; Lu M; Zhou L; Zou C
Technol Cancer Res Treat; 2020; 19():1533033820905832. PubMed ID: 32031054
[TBL] [Abstract][Full Text] [Related]
40. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
